Antibodies relating to PIVKA-II and uses thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9120862
APP PUB NO 20120020972A1
SERIAL NO

12843490

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present disclosure relates to antibodies and immunoassay methods for use in the diagnosis, treatment and prevention of hepatocellular carcinoma (HCC), liver cancer and related conditions.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ABBOTT JAPAN CO LTD278 MATSUHIDAI MATSUDO-SHI CHIBA-KEN

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Beligere, Gangamani S Grayslake, US 9 27
Dowell, Barry Lee Mundelein, US 3 14
Yoshida, Eisaku Kashiwa, JP 6 9
Yoshimura, Toru Matsudo, JP 32 159

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Mar 1, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00